Skip to main content

Association between visceral lipid accumulation indicators and gallstones: a cross-sectional study based on NHANES 2017–2020

Abstract

Background

Obesity is a major contributing factor to the formation of gallstones. As early identification typically results in improved outcomes, we explored the relationship between visceral lipid accumulation indicators and the occurrence of gallstones.

Methods

This cross-sectional study involved 3,224 adults. The researchers employed multivariable logistic regression, smoothed curve fitting (SCF), threshold effects analysis, and subgroup analysis to examine the relationship between metabolic scores for visceral fat (METS-VF), waist circumference (WC), lipid accumulation products (LAP), and visceral adiposity index (VAI) and gallstones. A Least Absolute Shrinkage and Selection Operator (LASSO) regression analysis was used to identify key factors which were then used in the construction of a nomogram model. The diagnostic efficacy of this model in detecting gallstones was then determined using receiver operating characteristic curves.

Results

Visceral lipid accumulation indicators were strongly linked to the likelihood of having gallstones. Specific saturation effects for METS-VF, WC, LAP, and VAI and gallstones were determined using SCF. The inflection points for these effects were found to be 8.565, 108.400, 18.056, and 1.071, respectively. Subgroup analyses showed that associations remained consistent in most subgroups. The nomogram model, which was developed using critical features identified by LASSO regression, demonstrated excellent discriminatory ability, as indicated by an area under the curve value of 0.725.

Conclusions

Studies have shown that increases in METS-VF, WC, LAP, and VAI are linked to increased prevalences of gallstones. The nomogram model, designed with critical parameters identified using LASSO regression, exhibits a strong association with the presence of gallstones.

Introduction

Gallstones are a medical condition marked by the development of calculi in the gallbladder or bile ducts, primarily as a result of abnormally elevated amounts of cholesterol or bilirubin in the bile. Cholesterol stones are the predominant type, while bilirubin stones are most often associated with hemolytic disorders or abnormal liver function. Epidemiological studies indicate that approximately 10–20% of adults are diagnosed with gallstones [1]. The total annual cost of cholecystectomies and subsequent office visits in the USA is approximately $6.5 billion [2]. In 2015, 1.5 million people sought medical care for gallstone-related conditions, with a total national expenditure of $10.3 billion dedicated to gallstones [3], which places a considerable burden on individuals and society. Although gallstones are usually asymptomatic, over 20% of individuals may have issues like biliary colic or infection as adults, and 1–2% may experience serious complications [1, 4, 5]. Therefore, the search for novel and more precise biomarkers is crucial in achieving the timely identification of gallstones.

Multiple research investigations have demonstrated that obesity plays a substantial contributing factor in the induction of gallstones [1, 6]. One of the distinguishing features of obesity is the accumulation of visceral fat. Visceral fat has a more significant role on health compared to subcutaneous fat. It is a red flag for obesity and predisposes individuals to metabolic disorders which, in turn, may raise their susceptibility to cardiovascular disease, diabetes, gallstones, and fatty liver [7, 8]. However, traditional measurements, including body mass index (BMI), only provide a rough assessment of obesity and are unable to differentiate between subcutaneous and visceral fats. Although waist circumference (WC) can indicate the degree of visceral fat accumulation, its accuracy may be affected by body size, sex, age, and ethnicity in different individuals [9, 10]. Consequently, in order to overcome the constraints of WC, scholars have suggested the development of new metrics to precisely assess the buildup of visceral fat. The metabolic score for visceral fat (METS-VF), lipid accumulation product (LAP), and visceral adiposity index (VAI) serve as dependable markers of visceral fat accumulation. Many previous investigations have established strong associations between these metrics and various diseases [11,12,13,14].

However, the relationship between visceral lipid accumulation indicators and the likelihood of developing gallstones remains uninvestigated. Hence, the present research employed National Health and Nutrition Examination Survey (NHANES) data from 2017 to 2020 in an attempt to elucidate the potential association between these indicators and prevalence of gallstones.

Methods

Study population

The NHANES, conducted by the National Center for Health Statistics (NCHS) within the Centers for Disease Control and Prevention, constitutes a significant health and nutrition survey initiative, begun within the 1960s to collect the health and nutritional condition of the American population, including both adults and children. This study employs NHANES data from 2017 to 2020. Figure 1 illustrates the exclusion criteria applied as follows: (1) age < 20 years; (2) incomplete gallstones questionnaire; and (3) missing METS-VF, WC, VAI, and LAP information. Ultimately, a total of 3,224 samples were included.

Fig. 1
figure 1

A flowchart showing the selection of study participants

Definition of gallstones

To determine whether individuals had gallstones, a survey question was phrased as: “Have you ever received a medical diagnosis of gallstones from a doctor?” Participants who acknowledged having gallstones were classified as gallstone patients, whereas those who denied having gallstones were placed in the nongallstone category.

Exposure factors measurement

Lipid accumulation indicators were determined to be the exposure variables investigated by the researchers. These variables were calculated using the formulas provided below [9]. Laboratory data provided information on triglycerides (TG), fasting blood glucose (FBG), and high-density lipoprotein cholesterol (HDL-C), whereas BMI, WC, and height data were obtained at the mobile screening center. In the METS-VF calculation, the value for sex was set to 1 for males and 0 for females [9, 15].

$$\:Males:\:LAP=\left(WC-65\right)\times\:TG$$
$$\:Females:\:LAP=\left(WC-58\right)\times\:TG$$
$$\begin{aligned}Males:\:VAI&=\left(\frac{WC}{39.68+1.88\times{BMI}}\right)\\& \quad\times\left(\frac{TG}{1.03}\right)\times\left(\frac{1.31}{HDL-C}\right)\end{aligned}$$
$$\begin{aligned}Females:\:VAI&=\left(\frac{WC}{36.58+1.89\times{BMI}}\right)\\& \quad\times\left(\frac{TG}{0.81}\right)\times\left(\frac{1.52}{HDL-C}\right)\end{aligned}$$
$$\:WHtR=\frac{WC}{Height}$$
$$\:METS-IR=\frac{\text{ln}\left(2\times\:FBG+TG\right)\times\:BMI}{\text{ln}\left(HDL-C\right)}$$
$$\begin{aligned}METS-VF&=4.466+0.01\times{\left(\text{ln}\left(METS-IR\right)\right)}^{3}\\& \quad+3.329\times{\left(\text{ln}\left(WHtR\right)\right)}^{3}+0.319\\& \quad\times{gender}+0.594\times\text{ln}\left(age\right)\end{aligned}$$

Covariables

Sex, age, race, education, and the income-to-poverty ratio were considered to be the demographic covariables in the study. Variables derived from questionnaires included the following: smoking (individuals categorized as smokers had consumed at least one hundred cigarettes during their lifespan); alcohol use (individuals who have consumed alcohol were considered drinkers); and a history of medical disorders including diabetes and hypertension. These were accordingly documented on the basis of the participants’ affirmative responses.

Statistical analysis

Visceral lipid accumulation indices were categorized by quartiles, and the lowest quartile was used as the reference group. Continuous variables were expressed as median and interquartile range (IQR) due to their non-normal distribution, which was determined by the Kolmogorov-Smirnov test (Table S1 and Figure S1), and categorical variables were expressed as proportions. Differences between groups for categorical variables were assessed by the chi-square test, while differences between groups for continuous variables were analyzed using the Mann-Whitney U test.

To explore the odds ratios (ORs) and 95% confidence intervals (CIs) between gallstones and these indicators, multivariable logistic regression was used. We constructed three regression models: model 1 (unadjusted), model 2 (adjusted only for sex, age, race, education, and marital status), and model 3 (fully adjusted for all covariables).

In addition, we assessed the potential nonlinear relationship between gallstones and visceral lipid accumulation metrics by smoothed curve fitting (SCF). The threshold effect of gallstones with these indicators was investigated by using a segmented linear regression model.

Subgroup analysis and interaction testing were used to delve deeper into potential differences across different populations. Sensitivity analysis was conducted to further assess the robustness of the outcomes. Total blood cholesterol was first adjusted to minimize its effect on gallstones. Second, participants with a history of smoking and diabetes were excluded, and then the association of these metrics with gallstones was reanalyzed in the remaining participants to check whether the results remained stable in the healthy population.

A Least Absolute Shrinkage and Selection Operator (LASSO) regression analysis was employed to evaluate all covariables as well as the indicators of visceral lipid accumulation. The penalty parameter lambda (λ) was determined using a process of 10-fold cross-validation, as shown in Fig. 3A. The algorithm was executed for 1,000 iterations in order to guarantee precision in this study. The model exhibiting the highest value within one standard error of the minimal binomial deviation, denoted as λ (λ = 0.0171), was consistent with prior published findings (Fig. 3B). Six variables (sex, age, race, hypertension, WC, and LAP) were initially chosen to construct a preliminary nomogram model. However, after conducting a statistical analysis, only five factors, namely sex, age, race, hypertension, and WC, had a significant association with the model. The discriminative ability of the nomogram model to recognize gallstones was verified via the receiver operating characteristic (ROC) curve.

Missing values were filled in using multiple imputations. A p-value < 0.05 was considered significant. R and EmpowerStats were implemented for the statistical analyses.

Results

Baseline characteristics

This research included 3,224 individuals who fulfilled specific inclusion and exclusion criteria. Among these participants, 54.68% were females. Participants had an average age of 50.97 ± 17.38 years. Overall, 2,886 (89.52%) participants did not have gallstones and 338 (10.48%) had gallstones. The mean METS-VF, WC, LAP, and VAI were 8.28 ± 1.67, 99.25 ± 16.79, 43.93 ± 34.93, and 1.39 ± 1.02, respectively. Table 1 contains an elaborate account of the participants. In contrast to participants without gallstones, those with gallstones were more likely to be female; older in age (≥ 60 years); non-Hispanic white; married or living with a partner; diagnosed with diabetes; and exhibit higher levels of METS-VF, WC, LAP, and VAI (each p < 0.05).

Table 1 Baseline characteristics of participants from National Health and Nutrition Examination Survey (NHANES) 2017–2020

Association between METS-VF, WC, LAP, and VAI and gallstones

Table 2 presents the connection between visceral lipid accumulation indicators and the likelihood of having gallstones. We designed three distinct models for this analysis. Additionally, for enhanced clarity and analysis, we categorized these indicators into four levels. Model 1 showed that higher visceral lipid accumulation index scores were related to an increased prevalence of gallstones. After considering all covariables (model 3), we found that a notable connection between the four indicators and gallstones remained. More precisely, the occurrence of gallstones in the upper quartile of the METS-VF was demonstrated to be 238.8% more than that in the lower quartile of the METS-VF (OR = 3.338, 95% CI: 2.158–5.164). The prevalence of gallstones in the upper quartile of the WC was found to be 215.4% more than that observed in the lower quartile of the WC (OR = 3.154, 95% CI: 2.173–4.578). The frequency of gallstones in the top quartile of the LAP was 148.1% superior to in the bottom of the LAP (OR = 2.481, 95% CI: 1.697–3.626). A significant increase of 88.5% in the occurrence of gallstones was seen in Q4 of VAI compared to Q1 (OR = 1.885, 95% CI: 1.304–3.37).

Table 2 Association of METS-VF, WC, LAP, VAI and gallstones

To further visualize the link between visceral lipid accumulation indicators and gallstones, SCF was performed based on Model 3. Figure 2 shows a nonlinear association between the four indicators and prevalence of gallstones. Subsequently, a threshold effect analysis was conducted to elucidate the association (Table 3). The study identified the inflection point of METS-VF as 8.565, with a log-likelihood ratio of < 0.001. This suggests that a reduction in METS-VF below 8.565 is linked to a 101.4% raised the probability of having gallstones for every additional one unit in METS-VF. When METS-VF levels exceeded 8.565, the relation between METS-VF and gallstone occurrence disappeared, indicating that subsequent elevations in METS-VF levels did not yield a statistically significant rise in gallstone prevalence. The findings on VAI exhibited a consistent pattern, showing an inflection point of 1.071 (log-likelihood ratio < 0.001). This indicates that VAI had varying effects on the prevalence of gallstones below and beyond this threshold. Remarkably, we discovered that the association between WC and LAP, with gallstone occurrence, exhibited a consistent pattern on both sides of the critical threshold.

Fig. 2
figure 2

The nonlinear relationship between indicators of visceral lipid accumulation and gallstones. The solid red line indicates a smooth curve fit between the variables. The blue band indicates the 95% confidence interval of the fit

Table 3 Threshold effect analysis of METS-VF, WC, LAP, and VAI on gallstones using a two-piecewise logistic regression model in adults in the NHANES 2017–2020

Subgroup analysis

The association between METS-VF, WC, LAP, and VAI and gallstones was consistent in most subgroups, with no significant interaction observed (Figure S2). Notably, an interaction with statistical significance was observed between METS-VF, WC, LAP, and VAI and sex (p for interaction < 0.05). While a statistically significant positive association was found in females, this connection lost its significance among males. This indicates that elevated levels of visceral lipid accumulation indicators may increase the likelihood of gallstones in females.

LASSO regression and the nomogram model

We conducted LASSO regression and developed a nomogram model (Fig. 3A and B). The ROC curves demonstrated that the constructed nomogram model exhibited superior discriminatory ability when compared to METS-VF, WC, LAP, and VAI. The area under the curve (AUC) value was 0.725 (Fig. 3D). The results of the 10-fold cross-validation show that the average AUC value of the final model was 0.729 (Figure S3), which is close to the AUC value previously analyzed by the ROC curve (Fig. 3D), further demonstrating the robustness and strong association with gallstone occurrence.

Fig. 3
figure 3

LASSO regression analysis was used to screen the factors most associated with gallstones, and the results of the predictive modeling were based on this. (A) Plot for LASSO regression coefficients. (B) Crossvalidation plot. (C) Nomogram model based on the key dietary factors screened by LASSO regression, and the red points show an example. For the 64-year-old female participants with gallstones, the odds of having gallstones increased by 48.6%. (D) ROC curve for evaluating the diagnostic power of the nomogram model in this study

Sensitivity analysis

Results remained robust across multiple sensitivity analysis (Table S2). Specifically, after adjusting for total cholesterol, visceral lipid accumulation indicators consistently displayed a positive association with the likelihood of developing gallstones in all four models. Furthermore, the results remained consistent even after individuals with a pre-existing smoking or diabetes background were removed from the analysis.

Discussion

This study is the first to use the NHANES database to examine the association between multiple visceral lipid accumulation indicators and gallstones, including a total of 3,224 participants. The findings demonstrated a statistically substantial positive relationship between these indicators and the occurrence of gallstones. Importantly, a nonlinear association was observed between MEST-VF, WC, LAP, and VAI and gallstones, and the respective inflection points were identified. This suggests a strong connection between these indicators and gallstones within a certain range, implying that maintaining ideal levels of MEST-VF, WC, LAP, and VAI has potential clinical significance in reducing the prevalence of gallstones. In addition, these positive associations were largely consistent across population settings. Moreover, the nomogram model derived from the major parameters developed in this study has a good diagnostic ability in identifying gallstones.

Studies have indicated a close connection between obesity and the occurrence of gallstones, with visceral fat accumulation being a significant risk factor [16, 17]. A prospective cohort study demonstrated that obesity promotes gallstone formation independently, even in metabolically healthy individuals [18]. Furthermore, a prospective study spanning a duration of 2 years has established a noteworthy link between abdominal obesity and the onset of asymptomatic cholelithiasis [19]. Sekine et al. conducted an analysis on 717 participants who underwent both computed tomography (CT) and ultrasound examinations. They examined the participants’ BMI and subcutaneous fat and visceral fat areas, finding a relationship between the accumulation of abdominal visceral fat and an elevated risk of occurrence of gallstones [8]. Additionally, other research has indicated substantial associations between various obesity markers and gallstones [20,21,22,23]. For instance, Zhang et al., in a cross-sectional study involving 6,848 participants, found positive associations between multiple obesity markers and occurrence of gallstones [22]. Similarly, another cross-sectional study of 7,409 participants demonstrated a positive relationship between elevated VAI levels and a higher frequency of gallstones, as well as an earlier onset of gallbladder stone surgery [23].

Although substantial evidence confirms a robust association between obesity and gallstones, particularly the significant risk posed by abdominal visceral fat accumulation, the role of specific visceral lipid accumulation indicators in gallstone formation remains underexplored. While studies have examined the relationship between common obesity indicators, such as BMI, WC, and VAI and gallstones, fewer studies have specifically investigated the association of emerging visceral lipid accumulation indicators like METS-VF and LAP. The present study makes certain improvements and expands on the existing literature. First, unlike Sekine et al. who used CT and ultrasound for adiposity measurements, the present study focused on five key variables, namely sex, age, race, hypertension, and WC, which can be easily accessed through routine clinical data, possessing a higher degree of convenience and cost-effectiveness. Furthermore, these factors may provide a simple and actionable clinical tool in the assessment of cholelithiasis. Compared with methods relying on expensive imaging technology, the selection of variables in this study is simpler and more practical for large-scale clinical screening. Second, unlike Zhang et al. and other cross-sectional studies that used only a single obesity indicator, our model highlights more factors associated with gallstones and shows higher AUC values through ROC curve analysis, demonstrating its superiority in estimating the likelihood of gallstones. Compared with studies relying only on obesity indicators, this model was able to assess the probability of gallstone occurrence more precisely. This provides a practical tool for future mass screening and opens up new ideas for the study of the association between obesity and gallstones.

Visceral obesity and gallstone formation are intricately connected through a variety of mechanisms (Fig. 4). The accumulation of visceral fat is a crucial element in the occurrence of gallstones as it leads to insulin resistance (IR), a significant contributor to the formation of these stones. IR promotes increased cholesterol synthesis while simultaneously reducing the production of bile salts. This dual effect disrupts the delicate balance between cholesterol and bile salts, leading to elevated cholesterol saturation in bile—a critical condition that predisposes individuals to gallstone formation [24, 25]. Moreover, visceral obesity is frequently associated with hepatic steatosis, or fatty liver, which further aggravates cholesterol metabolism disorders. The presence of hepatic steatosis results in an increased cholesterol concentration within the bile, thereby amplifying the susceptibility of gallstone occurrence [26,27,28].

Fig. 4
figure 4

Visceral obesity significantly elevates the risk of gallstone formation through various interconnected mechanisms. Created with BioRender.com

In addition to these metabolic disturbances, visceral obesity can also impair gallbladder motility. The reduced contractility of the gallbladder due to excess visceral fat leads to incomplete bile emptying, creating an environment conducive to cholesterol deposition within the gallbladder, which significantly raises the likelihood of gallstone formation [29, 30]. Furthermore, visceral obesity is linked to gut microbiota dysbiosis, a condition characterized by decreased microbial diversity and an imbalance in specific bacterial populations. These alterations in the gut microbiota can significantly affect the metabolism of bile acids, enhancing the enterohepatic circulation of cholesterol and thus contributing further to the risk of gallstones [31, 32]. The dysregulated endocrine function of adipose tissue in the context of obesity also plays a crucial role [33]. Abnormal secretion of hormones and cytokines, including leptin, adiponectin, and resistin, disrupts normal cholesterol metabolism and alters bile composition, which further increases the susceptibility to gallstone formation [34,35,36]. Additionally, changes in sex hormone levels, particularly elevated estrogen levels often observed in obese individuals, especially women, can exacerbate the progress of cholesterol gallstones. Estrogen affects cholesterol metabolism and bile composition, thereby intensifying the risk of gallstone occurrence in those with visceral obesity [37, 38]. In summary, visceral obesity directly contributes to gallstone formation through mechanisms such as IR and hepatic steatosis and indirectly increases the risk through multiple interconnected pathways. These include impaired gallbladder function, gut microbiota dysbiosis, endocrine disturbances in adipose tissue, and alterations in hormone levels. Together, these factors create a complex network of interactions that significantly elevate the likelihood of gallstone formation in individuals with visceral obesity.

In this study, subgroup analysis revealed that females with higher levels of visceral fat accumulation were significantly more prone to developing gallstones compared to their males. This increased susceptibility in women may be linked to sex-specific physiological factors, particularly those related to hormonal differences. Elevated levels of estrogen in females, especially during certain life stages such as pregnancy or post menopause, can induce changes in lipid metabolism. These hormonal fluctuations often result in an increased saturation of cholesterol in bile, a key precursor to gallstone formation. This physiological process, driven by estrogen, may therefore affect the elevated prevalence of gallstones identified in women [39]. Furthermore, the accumulation of visceral fat is strongly connected with IR and metabolic syndrome (MetS), both of which are significant contributors to the occurrence of gallstones. The presence of IR leads to alterations in glucose and lipid metabolism, which exacerbates cholesterol saturation in bile and impairs gallbladder motility, creating an environment conducive to gallstone formation [40,41,42]. Postmenopausal women are particularly vulnerable to an increase in visceral fat, a change that is often accompanied by a worsening of IR. This combination of factors may further heighten the risk of gallstones in this demographic, making them a particularly high-risk group [43]. Overall, these mechanisms suggest that women with elevated levels of visceral fat indicators have a greater propensity for gallstone occurrence compared to males. This finding underscores the importance of targeted clinical interventions and preventive measures aimed at addressing the specific needs of this high-risk population. By focusing on early detection and the management of visceral fat accumulation, especially in women, healthcare providers can potentially reduce the frequency of gallstones and improve overall outcomes for these individuals.

The ROC curves revealed that the indicators of visceral lipid accumulation exhibited limited diagnostic accuracy in relationship to gallstone occurrence. Given this limitation, we proceeded to employ LASSO regression analysis to identify variables that were more strongly linked to gallstone formation. Through this analysis, we discovered that sex, age, race, hypertension, WC, and LAP were all highly correlated with the presence of gallstones. Among these variables, sex, age, race, hypertension, and WC were identified as having a statistically significant association with gallstone formation. Consequently, these factors were selected for inclusion in the model due to their strong association with the outcome. The choice to incorporate these specific variables was based on their robust association with gallstones, as determined by statistical analysis. Notably, the association between the primary parameters investigated in the present research and gallstones has already been documented in the literature [1, 18, 22]. This consistency with existing research underscores the validity of our results and the significance of variables in forecasting the potential probability of gallstones.

Although this study model only includes sex, age, race, hypertension, and WC, these variables can indirectly reflect multiple high-risk factors for gallstones. Sex and age are important factors in gallbladder function changes. Women, due to higher estrogen levels, especially during pregnancy and menopause, face an increased risk of cholesterol supersaturation, which leads to stone formation [39]. Advancing age may diminish gallbladder contraction, hence elevating the risk of bile stasis and the production of gallstones [1, 44]. Racial differences reflect variations in metabolism, dietary habits, and genetic backgrounds among different populations [1]. The higher prevalence of gallstones in Mexican Americans and Native Americans suggests the role of genetic factors and lifestyle [1]. Hypertension, as a manifestation of MetS, is associated with systemic inflammation and biliary inflammation. MetS is also considered a substantial risk factor for gallstones [1, 45]. As an indicator of abdominal obesity, WC can reflect abnormal cholesterol metabolism and lifestyle factors, such as a high-fat diet and insufficient exercise, as well as the potential risk of gallstones [46, 47]. Therefore, although the model cannot directly incorporate high-risk factors such as gallbladder dysfunction, biliary inflammation, and lifestyle, the existing variables can indirectly reflect their effects on gallstone formation. However, given the lack of relevant direct variables in the NHANES database, our model still has certain limitations in explaining the multifactorial pathophysiology of gallstone formation.

Study strengths and limitations

The present analysis has some notable research strengths. Adjustments were made to account for distracting variables that could potentially interfere with the outcomes and which established a connection between visceral lipid accumulation indicators and gallstones. Furthermore, the nonlinear associations of these indicators with gallstones were explored by SCF and threshold effect analysis. Ultimately, a LASSO regression analysis was used to figure out the prominent characteristics related to gallstones and construct a nomogram model with enhanced discriminatory capability.

However, the implementation of a cross-sectional design in the present investigation presents constraints in terms of the ability to demonstrate causal links among the variables. In addition, completely eliminating the effects of all potential variables could distort the results. Finally, the NHANES database used in this study did not contain direct measurements of visceral fat such as CT or MRI, so we chose current widely recognized indirect indicators, such as METS-VF, WC, LAP, and VAI. These indicators have high operability in large-scale population studies and are reliable assessment tools for visceral fat accumulation that reflect individual metabolic risk [11,12,13,14, 48, 49]. In the absence of direct measurement data, these indirect indicators can reasonably reflect the association between visceral fat accumulation and gallstone occurrence. However, compared with direct measurements such as CT or magnetic resonance imaging (MRI), these indirect indicators do not provide precise quantification or distribution information of visceral fat, which may lead to underestimation or overestimation of the extent of visceral fat accumulation, thus affecting the accuracy of the association between gallstones and visceral fat accumulation.

To enhance the validation of this study’s findings, future studies should collect more clinical data based on direct measurements of visceral fat by CT or MRI through a retrospective or prospective design. In addition, integrating clinical data from other databases and combining direct measurements with indirect measurements would help reveal the potential association between visceral fat accumulation and gallstone occurrence more comprehensively, thereby deepening the understanding of this relationship and further validating the findings of this study.

Conclusions

The findings demonstrate a noteworthy relationship between visceral lipid accumulation indicators and the probability of developing gallstones. The model we constructed demonstrates the potential to identify individuals with a predisposition to gallstone formation before the onset of clinical symptoms: and supports earlier and more targeted interventions, particularly in addressing modifiable risk factors such as visceral fat accumulation. Managing visceral fat may be crucial in reducing the likelihood of gallstone formation and potentially decreasing the need for surgical treatments such as cholecystectomy. Compared to ultrasound, the model offers significant advantages in optimizing gallstone screening and resource allocation, enhancing early risk management. However, while the model shows promise, additional research is required to validate its efficacy in routine clinical practice and to explore how best to integrate it with existing diagnostic protocols to strengthen preventive care strategies.

Data availability

No datasets were generated or analysed during the current study.

Abbreviations

AUC:

Area Under the Curve

BMI:

Body Mass Index

CIs:

Confidence Intervals

FBG:

Fasting Blood Glucose

HDL-C:

High-Density Lipoprotein Cholesterol

IR:

Insulin Resistance

LAP:

Lipid Accumulation Products

LASSO:

Least Absolute Shrinkage and Selection Operator

MetS:

Metabolic Syndrome

METS-VF:

Metabolic Score for Visceral Fat

NCHS:

National Center for Health Statistics

NHANES:

Nutrition Examination Survey

ORs:

Odds Ratios

ROC:

Receiver Operating Characteristic

SCF:

Smoothed Curve Fitting

TG:

Triglycerides

VAI:

Visceral Adiposity Index

WC:

Waist Circumference

References

  1. Lammert F, Gurusamy K, Ko CW, Miquel JF, Méndez-Sánchez N, Portincasa P, van Erpecum KJ, van Laarhoven CJ, Wang DQ: Gallstones. Nat Rev Dis Primers. 2016;2:16024.

    Article  PubMed  Google Scholar 

  2. Wang X, Yu W, Jiang G, Li H, Li S, Xie L, et al: Global Epidemiology of Gallstones in the 21st Century: A Systematic Re view and Meta-Analysis. Clin Gastroenterol Hepatol. 2024;22:1586–1595.

  3. Peery AF, Crockett SD, Murphy CC, Jensen ET, Kim HP, Egberg MD, et al: Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021. Gastroenterology. 2022;162:621–644.

  4. Tanaka H, Imasato M, Yamazaki Y, Matsumoto K, Kunimoto K, Delpierre J, et al: Claudin-3 regulates bile canalicular paracellular barrier and choleste rol gallstone core formation in mice. J Hepatol. 2018;69:1308–1316.

  5. Zhu Q, Sun X, Ji X, Zhu L, Xu J, Wang C, Zhang C, Xue F, et al: The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. Scientific reports. 2018;6:29937.

  6. Di Ciaula A, Garruti G, Frühbeck G, De Angelis M, de Bari O, Wang DQH, et al: The Role of Diet in the Pathogenesis of Cholesterol Gallstones. Current medicinal chemistry. 2019;26:3620–3638.

  7. Ibrahim MM: Subcutaneous and visceral adipose tissue: structural and functional di fferences. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2010;11:11–18.

  8. Sekine K, Nagata N, Sakamoto K, Arai T, Shimbo T, Shinozaki M, et al: Abdominal visceral fat accumulation measured by computed tomography as sociated with an increased risk of gallstone disease. J Gastroenterol Hepatol. 2015;30:1325–1331.

  9. Deng C, Ke X, Lin L, Fan Y, Li C: Association between indicators of visceral lipid accumulation and infertility: a cross-sectional study based on U.S. women. Lipids Health Dis. 2024;23:186.

  10. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, et al: Waist Circumference and Cardiometabolic Risk: a Consensus Statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring, Md). 2007;15:1061–1067.

  11. Ahn N, Baumeister SE, Amann U, Rathmann W, Peters A, Huth C, et al: Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes. Scientific reports. 2019;9:9693.

  12. Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Viveros-Ruiz TL, Almeda-Valdes P, Gomez-Velasco D, et al: Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra -abdominal fat content and cardio-metabolic health. Clinical nutrition (Edinburgh, Scotland). 2020;39:1613–1621.

  13. Zhou T, Chen S, Mao J, Zhu P, Yu X, Lin R: Association between obstructive sleep apnea and visceral adiposity ind ex and lipid accumulation product: NHANES 2015-2018. Lipids Health Dis. 2024;23:100.

  14. Deng C-Y, Ke X-P, Guo X-G: Investigating a novel surrogate indicator of adipose accumulation in relation to erectile dysfunction. Lipids Health Dis. 2024;23:139.

  15. Guo Z, Li G, Chen Y, Fan S, Sun S, Hao Y, et al: Could METS-VF provide a clue as to the formation of kidney stones? Front Endocrinol. 2023;14:1166922.

  16. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL: Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut. 2006;55:708–714.

  17. Hsu H-Y, Huang C-Y, Hwang L-C: Sex difference of the predictive value of BMI, waist circumference and percentage body fat mass for gallstone disease. Br J Nutr. 2019;121:955–960.

  18. Man S, Gao Y, Lv J, Tong M, Yin J, Wang B, et al: Metabolically healthy obesity was significantly associated with increa sed risk of gallstones. Eur J Endocrinol. 2022;186:275–283.

  19. Tsai C-J, Leitzmann MF, Willett WC, Giovannucci EL: Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr. 2004;80:38–44.

  20. Wei C, Zhang G: Association between body roundness index (BRI) and gallstones: results of the 2017-2020 national health and nutrition examination survey (NHANES). BMC Gastroenterol. 2024;24:192.

  21. Wen S-H, Tang X, Tang T, Ye Z-R: Association between weight-adjusted-waist index and gallstones: an analysis of the National Health and Nutrition Examination Survey. BMC Gastroenterol. 2024;24:40.

  22. Zhang J, Liang D, Xu L, Liu Y, Jiang S, Han X, et al: Associations between novel anthropometric indices and the prevalence of gallstones among 6,848 adults: a cross-sectional study. Front Nutr. 2024;11:1428488.

  23. Zhang G, Ding Z, Yang J, Wang T, Tong L, Cheng J, et al: Higher visceral adiposity index was associated with an elevated prevalence of gallstones and an earlier age at first gallstone surgery in US adults: the results are based on a cross-sectional study. Front Endocrinol. 2023;14:1189553.

  24. Tsai C-J, Leitzmann MF, Willett WC, Giovannucci EL: Macronutrients and insulin resistance in cholesterol gallstone disease. Am J Gastroenterol. 2008;103:2932–2939.

  25. Wang HH, Portincasa P, Liu M, Wang DQH: Effects of biliary phospholipids on cholesterol crystallization and growth in gallstone formation. Adv Ther. 2023;40:743–768.

  26. Liu F, Chen S, Li X, Li S, Xiao Y, Han J, et al: Obesity-induced hepatic steatosis is partly mediated by visceral fat a ccumulation in subjects with overweight/obesity: a cross-sectional study. Obes Facts. 2023;16:164–172.

  27. Zhang C, Dai W, Yang S, Wu S, Kong J: Resistance to cholesterol gallstone disease: hepatic cholesterol metabolism. J Clin Endocrinol Metabol. 2024;109:912–923.

  28. Acalovschi M: Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects. World J Gastroenterol. 2014;20:7277–7285.

  29. Bonfrate L, Wang DQH, Garruti G, Portincasa P: Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol. 2014;28:623–635.

  30. Petroni ML: Review article: gall-bladder motor function in obesity. Aliment Pharmacol Ther. 2000;2:48–50.

  31. Wang Q, Hao C, Yao W, Zhu D, Lu H, Li L, et al: Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation. BMC Gastroenterol. 2020;20:59.

  32. Grüner N, Mattner J: Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis. Int J Mol Sci. 2021;22:1397.

  33. Ricci R, Bevilacqua F: The potential role of leptin and adiponectin in obesity: a comparative review. Veterinary Journal (London, England : 1997). 2012;191:292–298.

  34. Méndez-Sánchez N, Bermejo-Martínez L-B, Viñals Y, Chavez-Tapia N-C, Vander Graff I, Ponciano-Rodríguez G, et al: Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects. World J Gastroenterol. 2005;11:6182–6187.

  35. Koshiol J, Castro F, Kemp TJ, Gao Y-T, Roa JC, Wang B, et al: Association of inflammatory and other immune markers with gallbladder cancer: results from two independent case-control studies. Cytokine. 2016;83:217–225.

  36. Jin C-G, Jiang F-R, Zhang J, Ma J-R, Ling X-F: Role of osteopontin in diet-induced brown gallstone formation in rats. Chin Med J. 2021;134:1093–1100.

  37. Yuan S, Wang L, Sun J, Yu L, Zhou X, Yang J, et al: Genetically predicted sex hormone levels and health outcomes: phenome-wide Mendelian randomization investigation. Int J Epidemiol. 2022;51:1931–1942.

  38. de Bari O, Wang HH, Portincasa P, Paik C-N, Liu M, Wang DQH: Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice. Eur J Clin Invest. 2014;44:1159–1168.

  39. Everson GT, McKinley C, Kern F, Jr: Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest. 1991;87:237–246.

  40. Bensussen A, Torres-Magallanes JA, Roces de Álvarez-Buylla E: Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue. Front Immunol. 2023;14:1014778.

  41. Di Ciaula A, Garruti G, Wang DQH, Portincasa P: Cholecystectomy and risk of metabolic syndrome. Eur J Intern Med. 2018; 53:3–11.

  42. Zhu Q, Xing Y, Fu Y, Chen X, Guan L, Liao F, et al: Causal association between metabolic syndrome and cholelithiasis: a Mendelian randomization study. Front Endocrinol. 2023;14:1180903.

  43. Ko S-H, Jung Y: Energy metabolism changes and dysregulated lipid metabolism in postmen opausal women. Nutr. 2021; 13:4556.

  44. Wang DQH: Aging per se is an independent risk factor for cholesterol gallstone f ormation in gallstone susceptible mice. J Lipid Res. 2002;43:1950–1959.

  45. Garruti G, Wang DQH, Di Ciaula A, Portincasa P: Cholecystectomy: a way forward and back to metabolic syndrome? Lab Invest. 2018;98:4–6.

  46. Tanamas SK, Shaw JE, Backholer K, Magliano DJ, Peeters A: Twelve-year weight change, waist circumference change and incident obe sity: the Australian diabetes, obesity and lifestyle study. Obesity (Silver Spring, Md). 2014;22:1538–1545.

  47. Chen L-Y, Qiao Q-H, Zhang S-C, Chen Y-H, Chao G-Q, Fang L-Z: Metabolic syndrome and gallstone disease. World J Gastroenterol. 2012; 18:4215–4220.

  48. Bullen AL, Katz R, Kumar U, Gutierrez OM, Sarnak MJ, Kramer HJ, et al: Lipid accumulation product, visceral adiposity index and risk of chronic kidney disease. BMC Nephrol. 2022;23:401.

  49. Yu P, Meng X, Kan R, Wang Z, Yu X: Association between metabolic scores for visceral fat and chronic kidney disease: A cross-sectional study. Front Endocrinol. 2022;13:1052736.

Download references

Acknowledgements

Not applicable.

Funding

This study was supported by the Natural Science Foundation of Guangdong Province (2021A1515010100).

Author information

Authors and Affiliations

Authors

Contributions

WGW wrote the main manuscript text. YCP, JLW and QZL gathered and examined the data. YCP and JLW analyzed the data. WC meticulously scrutinized, revised, and approved the manuscript. The work has undergone a comprehensive review and has received approval from all authors.

Corresponding author

Correspondence to Wei Chen.

Ethics declarations

Ethics approval and consent to participate

The survey protocol was approved by the NCHS Ethics Review Board. The approved protocol can be found at this link: https://www.cdc.gov/nchs/nhanes/irba98.htm. Additionally, every participant in the survey supplied written informed permission.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, W., Pei, Y., Wang, J. et al. Association between visceral lipid accumulation indicators and gallstones: a cross-sectional study based on NHANES 2017–2020. Lipids Health Dis 23, 345 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-024-02319-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-024-02319-2

Keywords